Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT00372450
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed primary cancer of the esophagus or gastroesophageal junction
* Squamous cell or other type
* Diagnosis of malignant dysphagia
* Disease deemed surgically inoperable, but may be any of the following:
* Locally contained
* Locally advanced
* Metastatic
* Unresponsive to previous chemoradiotherapy
* Recurrent despite previous surgical resection
* Must be either an inpatient OR outpatient at Johns Hopkins Hospital
* No known tracheal compression by tumor burden
PATIENT CHARACTERISTICS:
* Karnofsky performance status 50-100%
* Life expectancy ≥ 6 months
* Platelet count \> 50,000/mm³
* INR \< 1.5
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* Prior surgery, chemotherapy, biologic therapy, or radiotherapy allowed
* No concurrent surgery, chemotherapy, biologic therapy, or radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00372450
Study Brief:
Protocol Section:
NCT00372450